Granules India
Market cap ₹21,754 Cr
- P/E
- 27.91
- Day range
- ₹790.30 – ₹818.00
- 52-week range
- ₹529.85 – ₹923.65
- Volume
- 11.98 L
- Open
- ₹815.50
- Prev close
- ₹815.50
Latest results · Q2 FY27(consolidated)Revenue ₹1,560 Cr+20.3%Profit ₹182 Cr+39.2%Margin 11.7%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
GRANULES in NSE indices and F&O
Research profile
Composite 66 / 100Factor percentiles
Derived metrics
- Earn. yield
- 3.6%
- Graham no.
- ₹369.93
- vs Graham
- -53.6%
- ROE ÷ P/B
- 4.0%
- 12-1 mom.
- +50.0%
- Return / vol
- 1.53
- Magic Formula
- #279
- Piotroski
- 5/6
- FCF yield
- 1.1%
- PEG
- 0.71
Appears in 11 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 68 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹4.49 L Cr | 40.95 | 5.03 | 14.8% | 21.0% | 29.0% | 0.04 | +11.9% |
| Divi's LaboratoriesDIVISLAB | ₹2.93 L Cr | 87.19 | 16.88 | 16.2% | 22.0% | 43.0% | 0.00 | +35.4% |
| Torrent PharmaTORNTPHARM | ₹1.75 L Cr | 77.88 | 9.67 | 26.8% | 15.0% | 33.0% | 0.77 | +50.8% |
| Apollo HospitalsAPOLLOHOSP | ₹1.27 L Cr | 56.40 | 11.55 | 22.6% | 17.0% | 16.0% | 0.77 | +23.0% |
| Laurus LabsLAURUSLABS | ₹1.25 L Cr | 93.72 | 19.82 | 18.2% | 18.0% | 34.0% | 0.43 | +33.5% |
| Zydus LifesciencesZYDUSLIFE | ₹1.20 L Cr | 28.72 | 4.32 | 20.1% | 21.0% | 24.0% | 0.50 | +29.2% |
| Dr. Reddy's LabsDRREDDY | ₹1.17 L Cr | 41.63 | 2.97 | 11.6% | 13.0% | 20.0% | 0.19 | -1.5% |
| Granules IndiaGRANULES | ₹21,754 Cr | 27.91 | 3.37 | 13.5% | 16.0% | 22.0% | 0.17 | +20.3% |
| Sector median | ₹24,603 Cr | 43.68 | 5.46 | 15.1% | 17.0% | 24.0% | 0.17 | +22.7% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 7h agoHeadlines about Granules India from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 31.0
- Price / Book
- 3.31
- ROE (FY26)
- 13.5%
- ROCE (latest year)
- 16%
- Dividend yield
- 0.22%
Moving averages (NSE)
- 20-day
- ₹812.96
- Price below
- 50-day
- ₹834.49
- Price below
- 200-day
- ₹752.33
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- FII
- DII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,156 | 1,176 | 1,180 | 967 | 1,138 | 1,197 | 1,210 | 1,297 | 1,388 | 1,471 | 1,477 | 1,560 |
| YoY Sales growth | — | -2 | — | -19 | -2 | — | — | — | — | — | — | — |
| Expenses | 905 | 920 | 921 | 763 | 907 | 945 | 963 | 1,019 | 1,080 | 1,119 | 1,138 | 1,222 |
| Operating Profit | 250 | 256 | 259 | 203 | 230 | 252 | 247 | 278 | 308 | 352 | 339 | 338 |
| OPM % | 22% | 22% | 22% | 21% | 20% | 21% | 20% | 21% | 22% | 24% | 23% | 22% |
| Other Income | 1 | 2 | 2 | 3 | 6 | 33 | -10 | -1 | -4 | 25 | 2 | 11 |
| Interest | 29 | 29 | 27 | 26 | 27 | 24 | 24 | 29 | 29 | 33 | 21 | 21 |
| Depreciation | 52 | 53 | 53 | 53 | 57 | 64 | 69 | 72 | 74 | 82 | 80 | 84 |
| Profit before tax | 170 | 176 | 181 | 128 | 153 | 198 | 145 | 176 | 202 | 262 | 240 | 243 |
| Tax % | 26% | 26% | 26% | 24% | 23% | 23% | 22% | 26% | 26% | 23% | 25% | 25% |
| Net Profit | 126 | 130 | 135 | 97 | 118 | 152 | 113 | 131 | 150 | 202 | 180 | 182 |
| EPS in Rs | ₹5.18 | ₹5.35 | ₹5.56 | ₹4.01 | ₹4.85 | ₹6.27 | ₹4.64 | ₹5.38 | ₹6.19 | ₹8.13 | ₹7.26 | ₹6.67 |
From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-24 days since Mar 2021
+121 days since Mar 2021
-11 days since Mar 2021
+106 days since Mar 2021
-13 days since Mar 2021
Strengths, risks & growth
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages. [1]
Strengths
- Company has reduced debt.
Risks
- Promoter holding has decreased over last quarter: -0.62%
- The company has delivered a poor sales growth of 10.6% over past five years.
- Company has a low return on equity of 13.7% over last 3 years.
- Dividend payout has been low at 7.84% of profits over last 3 years
Compounded Sales Growth
- 10 Years
- +15%
- 5 Years
- +11%
- 3 Years
- +6%
- TTM
- +22%
Compounded Profit Growth
- 10 Years
- +17%
- 5 Years
- +2%
- 3 Years
- +5%
- TTM
- +37%
Stock Price CAGR
- 10 Years
- +23%
- 5 Years
- +21%
- 3 Years
- +30%
- 1 Year
- +44%
Return on Equity
- 10 Years
- +17%
- 5 Years
- +15%
- 3 Years
- +14%
- Last Year
- +14%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 38.81% | 38.02% | 38.01% | 37.39% | -0.62 pp |
| FII | 13.55% | 15.31% | 17.50% | 20.25% | +2.75 pp |
| DII | 17.47% | 17.01% | 16.11% | 15.33% | -0.78 pp |
| Public | 30.15% | 29.67% | 28.36% | 27.04% | -1.32 pp |
Filed with NSE for Sept 2026: promoters 37.39%, public 62.61%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 4.26% (+0.81 pp)- Promoters37.4%
- Foreign institutions20.3%
- Mutual funds4.3%
- Insurance6.9%
- Other domestic institutions4.1%
- Retail12.7%
- Others14.3%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Old Bridge Focused Fund | 0.64% | 3.06% | -0.34 pp |
| Aditya Birla SL Multi-Cap Fund | 0.62% | 1.91% | +0.72 pp |
| Aditya Birla SL Small Cap Fund | 0.56% | 2.09% | +0.53 pp |
| Sundaram Aggressive Hybrid Fund | 0.48% | 1.20% | +0.41 pp |
| Aditya Birla SL Value Fund | 0.41% | 1.34% | -0.38 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 29.4%
- Downside volatility
- 27.2%
- Worst 5% of days
- 3.0%
- Average of that tail
- 3.5%
- Max drawdown (1Y)
- 13.2%
- Below its peak
- 12.3%
Against the market
- Beta vs Nifty 50
- 0.78
- Correlation
- 0.36
- Relative strength (3M)
- -11.3%
- ATR (14)
- 4.0%
Return
- Return 1M
- -3.4%
- Return 3M
- -7.4%
- Return 6M
- +9.0%
- Return 1Y
- +45.0%
- vs 200-day average
- +6.0%
Momentum
- RSI (14)
- 44.7
- MACD histogram
- 0.52
- Stochastic %K
- 36.7
- ADX (14)
- 14.7
- +DI / −DI
- 16.3 / 21.6
- Money flow index
- 43.0
Participation
- Delivery (20d avg)
- 46.5%
- vs its 60-day baseline
- -2.9 pts
- Volume vs 20-day
- -0.3σ
- Close vs day's VWAP
- -0.4%
- 52-week position
- 72 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
5 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — passed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — passed
- Asset turnover improving — failed
- Free cash flow
- ₹235 Cr
- FCF yield
- 1.1%
- Cash conversion
- 1.33
- Accruals ratio
- -0.026
- Net debt
- ₹156 Cr
- Net debt / equity
- 0.02
- EV / sales
- 3.72
- PEG
- 0.71
- Capex intensity
- 10.4%
- Revenue CAGR
- 19.3%
- Profit CAGR
- 12.7%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Chigurupati Uma Devi Promoter Group · Preferential Offer | Buy | 2,48,80,342 | ₹364 Cr | 23 Oct 2026 |
Priyanka Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹50.0 L | 23 Oct 2026 |
Pragnya Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹50.0 L | 23 Oct 2026 |
Harsha Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹50.0 L | 23 Oct 2026 |
Chigurupati Uma Devi Promoter Group · Preferential Offer | Buy | 2,48,80,342 | ₹1092 Cr | 23 Oct 2026 |
Priyanka Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹1.5 Cr | 23 Oct 2026 |
Pragnya Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹1.5 Cr | 23 Oct 2026 |
Harsha Chigurupati Promoter Group · Preferential Offer | Buy | 34,188 | ₹1.5 Cr | 23 Oct 2026 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividend₹1.75
Dividend - Rs 1.75 Per Share
30 Jul 2026ex-date - dividend₹1.50
Dividend - Rs 1.50 Per Share
31 Jul 2025ex-date - dividend₹1.50
Annual General Meeting/Dividend - Rs 1.50 Per Share
30 Jul 2024ex-date - otherNot available — not reported in this filing
Annual General Meeting
3 Aug 2023ex-date - dividend₹1.50
Dividend - Rs 1.50 Per Share
3 Aug 2023ex-date - buybackNot available — not reported in this filing
Buy Back
22 Aug 2022ex-date - dividend₹0.75
Annual General Meeting/Dividend - Rs 0.75 Per Share
19 Jul 2022ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
17 Feb 2022ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
24 Nov 2021ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
5 Aug 2021ex-date - dividend₹0.75
Annual General Meeting/Dividend - Rs 0.75 Per Share
28 Jul 2021ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
8 Feb 2021ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
28 Oct 2020ex-date - dividend₹0.25
Annual General Meeting/Dividend - Rs 0.25 Per Share
5 Aug 2020ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
28 Jul 2020ex-date - buybackNot available — not reported in this filing
Buyback
19 Mar 2020ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 0.25 Per Share
30 Jan 2020ex-date - dividend₹0.25
Interim Dividend - Rs 0.25 Per Share
31 Oct 2019ex-date - dividendNot available — not reported in this filing
Annual General Meeting/ Dividend - Re 0.25 Per Share
21 Aug 2019ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 0.25 Per Share
8 Aug 2019ex-date
Company announcements
Schedule of Investor Meet
Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA)
Transcript of the Earnings Conference Call for Q2 and the half year of FY27
Audio recording of the Earnings Conference call for Q2 and the half -year of FY27
Monitoring Agency Report for the quarter ended on September 30, 2026
Investor Presentation to Analysts/Investors
Press Release
Unaudited financial results for the second quarter and half year ended on September 30,2026
Outcome of the Board meeting dated November 02, 2026.
Press Release
Intimation of Schedule of the Earnings Conference call for Q2 and Half year of FY27.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Chigurupati Uma Devi, Mrs Priyanka Chigurupati, ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs Chigurupati Uma Devi, Mrs Priyanka Chigurupati, ....
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Krishna Prasad Chigurupati & PACs
Granules India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve the unaudited financial results ....
Filed with BSE (scrip 532482); the last 45 days. Documents open at bseindia.com.
SEBI filings & orders
From SEBI's website. An order may concern the company, its officers or trading in its shares, and may be under appeal - read the order itself. Personal identifiers are withheld.
Buybacks, open offers & rights issues
- Buyback
Granules India Limited
12 Aug 2022Read on SEBI - Buyback - Post Offer Advertisement
Granules India Limited - Post Offer Advertisement
29 Jun 2020Read on SEBI - Buyback - Dispatch advertisement
GRANULES INDIA LIMITED - Dispatch advertisement
2 Jun 2020Read on SEBI - Buyback - Letter of Offer
GRANULES INDIA LIMITED - Letter of Offer
2 Jun 2020Read on SEBI - Buyback - Draft Letter of Offer
GRANULES INDIA LIMITED - Draft Letter of Offer
16 Mar 2020Read on SEBI
Regulatory orders
- Order
Order in respect of SPS Share Brokers Pvt Ltd in the matter of Granules India Ltd
12 Apr 2012Read on SEBI - Order
Order in repect of Arun Kumar Dalmia, M/s Satya Securities Ltd and Basant Marketing Ltd in the matter of Granules India Ltd
27 Aug 2010Read on SEBI - Adjudication order
Adjudication order against Satya Securities Ltd. and Basant Marketing pvt. Ltd. in the matter of Granules India Ltd
23 Jun 2009Read on SEBI - Order
Order in the matter of C Krishna Prasad in the scrip of Granules India Ltd.
14 Jan 2009Read on SEBI - Order
Order in the matter of Pacific Corporate Services Limited in the scrip of Granules India Limited
14 Jan 2009Read on SEBI
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Oct 2026TranscriptRecording
- Jul 2026TranscriptSlidesRecording
- May 2026TranscriptSlides
- Apr 2026SlidesRecording
- Jan 2026TranscriptSlidesRecording
Credit ratings
- Rating update · 19 Jan from icra
- Rating update · 16 Jan from fitch
- Rating update · 6 Nov 2024 from icra
- Rating update · 18 Oct 2024 from fitch
- Rating update · 22 Sep 2023 from fitch
- Rating update · 7 Aug 2023 from icra
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 2 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Granules India: common questions
Answered from the figures on this page.